✦ LIBER ✦

Intravenous epoprostenol treatment of patients with connective tissue disease and pulmonary arterial hypertension at a single center

✍ Scribed by Yuichiro Shirai,Hidekata Yasuoka,Tsutomu Takeuchi,Toru Satoh…

Book ID: 126348703
Publisher: Springer
Year: 2013
Tongue: English
Weight: 337 KB
Volume: 23
Category: Article
ISSN: 1439-7595
DOI: 10.1007/s10165-012-0828-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of Baseline Characteristics a

Comparison of Baseline Characteristics and Survival Between Patients With Idiopathic and Connective Tissue Disease–related Pulmonary Arterial Hypertension

✍ Maria J. Ruiz-Cano; Pilar Escribano; Rafael Alonso; Juan Delgado; Patricia Carre 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 477 KB

Efficacy of bosentan in the treatment of

Efficacy of bosentan in the treatment of a patient with mixed connective tissue disease complicated by pulmonary arterial hypertension

✍ Caterina Naclerio; Salvatore D’Angelo; Silvano Baldi; Gianluigi Tagliamonte; Sal 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 99 KB

Prevalence of pulmonary arterial hyperte

Prevalence of pulmonary arterial hypertension in patients with connective tissue diseases: a systematic review of the literature

✍ Yang, Xiaoqin; Mardekian, Jack; Sanders, Kafi N.; Mychaskiw, Marko A.; Thomas, J 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 495 KB

Dynamic perfusion MRI: Capability for ev

Dynamic perfusion MRI: Capability for evaluation of disease severity and progression of pulmonary arterial hypertension in patients with connective tissue disease

✍ Yoshiharu Ohno; Hisanobu Koyama; Munenobu Nogami; Daisuke Takenaka; Sumiaki Mats 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 888 KB

## Abstract ## Purpose To prospectively evaluate the capability of dynamic perfusion MRI for assessment of disease severity and progression to pulmonary arterial hypertension (PAH) in connective tissue disease (CTD) patients. ## Materials and Methods In all, 18 gender‐ and age‐matched CTD patien

PReS-FINAL-2267: Successful treatment of

PReS-FINAL-2267: Successful treatment of pulmonary arterial hypertension associated with connective tissue disease (PAH-CTD) with combination therapy of sildenafil and ambrisentan: a case report

✍ Yamaguchi, KI; Kishimoto, M; Okada, M 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 82 KB

The prevalence of undiagnosed pulmonary

The prevalence of undiagnosed pulmonary arterial hypertension in subjects with connective tissue disease at the secondary health care level of community-based rheumatologists (the UNCOVER study)

✍ Fredrick M. Wigley; Joao A. C. Lima; Maureen Mayes; David McLain; J. Lincoln Cha 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 2 views

## Abstract ## Objective Most of the data about the prevalence of pulmonary arterial hypertension (PAH) are from tertiary centers that are biased toward seeing more severe cases; therefore, the true prevalence of PAH among patients with connective tissue disease is unknown. We sought to determine